Lv3
210 积分 2025-05-16 加入
Targeting DNA damage response pathways in cancer
3天前
已完结
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications
3天前
已完结
Recent advances in DDR (DNA damage response) inhibitors for cancer therapy
3天前
已完结
Investigation into MAO B–Mediated Formation of CC112273, a Major Circulating Metabolite of Ozanimod, in Humans and Preclinical Species: Stereospecific Oxidative Deamination of (S)-Enantiomer of Indaneamine (RP101075) by MAO B
3天前
已完结
Selective Intracellular Delivery of Dexamethasone into Activated Endothelial Cells Using an E-Selectin-Directed Immunoconjugate
5天前
已关闭
Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)
10天前
已完结
Identification of 2-Pyridinylindole-Based Dual Antagonists of Toll-like Receptors 7 and 8 (TLR7/8)
10天前
已完结
The medicinal chemistry evolution of antibody–drug conjugates
12天前
已完结
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions
13天前
已完结
Determination of Hydroxamic Acids’ Acidity Constants in Water by NMR
21天前
已完结
皖公网安备34019202002308
